Lilly puts its stamp at #EHA26 with Jaypirca combo data in CLL, first clinical data from Ajax buyout

June 15, 2026 07:39 AM EDTUpdated 11:55 AM R&DPharma Lil­ly puts its stamp at EHA with Jaypir­ca com­bo da­ta in CLL, first clin­i­cal da­ta from Ajax buy­out Ayisha Sharma News Reporter Eli Lil­ly made a push in blood can­cer at this year’s Eu­ro­pean Hema­tol­ogy As­so­ci­a­tion meet­ing in Stock­holm over the week­end. The drug­mak­er pre­sent­ed da­ta for … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER